{"pageContent": "Background: Active surveillance (AS) is emerging as an alternative approach to limit the risk of overtreatment and impairment of quality of life (QoL) in patients with low-risk localised prostate cancer. Although most patients report high levels of QoL, some men may be distressed by the idea of living with untreated cancer.", "metaData": {"source": "Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis\nhttps://pubmed.ncbi.nlm.nih.gov/15322319/"}}